Concepedia

Carolina Säll

CS

6

Publications

171

Citations

6

H-Index

2012

Active since

Affiliations

University of Manchester(Current)

Novo Nordisk (Denmark)

Carolina Säll is an author at University of Manchester specializing in pharmacology, medicine, and cell biology.

Top concepts

Publications per year

2012–2023

6

Publications

6

A Comprehensive Assessment of Repaglinide Metabolic Pathways: Impact of Choice of In Vitro System and Relative Enzyme Contribution to In Vitro Clearance

Carolina Säll, J. Brian Houston, Aleksandra Galetin · Drug Metabolism and Disposition · 2012 · 48 citations

Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of Drug-Drug Interaction Risk

Michael Gertz, Nikolaos Tsamandouras, Carolina Säll et al. · Pharmaceutical Research · 2014 · 41 citations

, , +8

Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture

Lassina Badolo, Bente Jensen, Carolina Säll et al. · Xenobiotica · 2014 · 37 citations

, , +15

Progress Curve Mechanistic Modeling Approach for Assessing Time-Dependent Inhibition of CYP3A4

Howard Burt, Henry Pertinez, Carolina Säll et al. · Drug Metabolism and Disposition · 2012 · 20 citations

In Vitro CYP450 Enzyme Downregulation by GLP-1/Glucagon Coagonist Does Not Translate to Observed Drug-Drug Interactions in the Clinic

Carolina Säll, Lene Alifrangis, Kirsten Dahl et al. · Drug Metabolism and Disposition · 2022 · 15 citations · Full text

Rows per page

1–5 of 6